English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 21 Help

Selected(0)Clear Items/Page:    Sort:
Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells Journal article
Cai, Wanhua, Rong, Dade, Ding, Jiayu, Zhang, Xiaomei, Wang, Yuwei, Fang, Ying, Xiao, Jing, Yang, Shulan, Wang, Haihe. Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells[J]. Cancer Cell International, 2024, 24(1), 249.
Authors:  Cai, Wanhua;  Rong, Dade;  Ding, Jiayu;  Zhang, Xiaomei;  Wang, Yuwei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.3/5.0 | Submit date：2024/08/05
Breast Cancer  Er Stress  Perk/eif2α  Taxane  Tumor Drug Resistance  
Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer Journal article
Peng, Bo, Zhang, Siyuan, Chan, Ka Iong, Zhong, Zhangfeng, Wang, Yitao. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer[J]. Molecules, 2023, 28(2), 740.
Authors:  Peng, Bo;  Zhang, Siyuan;  Chan, Ka Iong;  Zhong, Zhangfeng;  Wang, Yitao
Favorite | TC[WOS]:14 TC[Scopus]:16  IF:4.2/4.6 | Submit date：2023/02/08
Ampk  Breast Cancer  Immunity  Metabolism  Metastasis  Multidrug Resistance  Natural Products  
High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level Journal article
Luo, Man, Fu, Afu, Wu, Renfei, Wei, Na, Song, Kai, Lim, Sierin, Luo, Kathy Qian. High Expression of G6PD Increases Doxorubicin Resistance in Triple Negative Breast Cancer Cells by Maintaining GSH Level[J]. International Journal of Biological Sciences, 2022, 18(3), 1120-1133.
Authors:  Luo, Man;  Fu, Afu;  Wu, Renfei;  Wei, Na;  Song, Kai; et al.
Favorite | TC[WOS]:29 TC[Scopus]:27  IF:8.2/8.3 | Submit date：2022/05/17
Doxorubicin  Drug Resistance  G6pd  Metastasis  Oxidative Stress  Triple Negative Breast Cancer  
Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment Journal article
Yousheng Mo, Wei Liu, Piaoxue Liu, Qiao Liu, Zhongyu Yuan, Qi Wang, Dongsheng Yuan, Xiao-Jia Chen, Tongkai Chen. Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment[J]. International Journal of Nanomedicine, 2022, 17, 6413-6425.
Authors:  Yousheng Mo;  Wei Liu;  Piaoxue Liu;  Qiao Liu;  Zhongyu Yuan; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:6.6/7.5 | Submit date：2023/01/30
Breast Cancer  Paclitaxel  Targeted Delivery  Multidrug Resistance  
Berberine and Momordin Ic regulate autophagy with opposite effects on the activity of anticancer agents Thesis
HAN Bing. Berberine and Momordin Ic regulate autophagy with opposite effects on the activity of anticancer agents[D]. Macau, University of Macau, 2021.
Authors:  HAN Bing
Favorite |  | Submit date：2022/07/28
Autophagy  Natural Compounds  Breast Cancer  Nsclc  Resistance  Egfr Tki  
Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells Journal article
Huang, Bin, Yip,Wai Kien, Wei, Na, Luo, Kathy Qian. Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells[J]. Cancer Letters, 2020, 490, 1-11.
Authors:  Huang, Bin;  Yip,Wai Kien;  Wei, Na;  Luo, Kathy Qian
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:9.1/8.3 | Submit date：2021/03/02
Acetyltanshinone Iia  Drug Resistance  Her2 Degradation  Her2-positive Breast Cancer  
Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells Journal article
Huang, B, Yip, WK, Na, W, Luo, KQ. Acetyltanshinone IIA is more potent than lapatinib in inhibiting cell growth and degrading HER2 protein in drug-resistant HER2-positive breast cancer cells[J]. Cancer Letters, 2020, 1-11.
Authors:  Huang, B;  Yip, WK;  Na, W;  Luo, KQ
Favorite |   IF:9.1/8.3 | Submit date：2022/08/26
Acetyltanshinone IIA  drug resistance  HER2-positive breast cancer  HER2 degradation  
The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer Journal article
Yang,Conglian, Tu,Kun, Gao,Hanlu, Zhang,Liao, Sun,Yu, Yang,Ting, Kong,Li, Ouyang,Defang, Zhang,Zhiping. The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer[J]. Biomaterials, 2020, 232(119751).
Authors:  Yang,Conglian;  Tu,Kun;  Gao,Hanlu;  Zhang,Liao;  Sun,Yu; et al.
Favorite | TC[WOS]:28 TC[Scopus]:29  IF:12.8/13.1 | Submit date：2021/03/02
Platinum(Iv) Prodrug  Adjudin  Self-assembly  Structure Transform  Drug Resistance  Triple-negative Breast Cancer  
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers Journal article
Wang, S. M.. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers[J]. European Journal of Cancer, 2019, 68-78.
Authors:  Wang, S. M.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:7.6/7.7 | Submit date：2022/07/27
Brca1  Breast Cancer  Cancer Resistance  Exome  Variation  
A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer. Journal article
Zhou, X, Wang, A, WANG, L, YIN, J, Wang, L., Di, L., Shan, L, WU, X. A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer.[J]. Front Pharmacol, 2019, 1-11.
Authors:  Zhou, X;  Wang, A;  WANG, L;  YIN, J;  Wang, L.; et al.
Favorite |   IF:4.4/5.0 | Submit date：2023/08/30
P-glycoprotein  breast cancer  danshensu  glycolysis  resistance  tetramethylpyrazine